SIFI, Italian leader in the development of therapeutic solutions to treat ophthalmic disorders, announces that it has appointed Andrea Quaglino as new Chief Financial Officer of the Company, as of today. Andrea Quaglino will report to Fabrizio Chines,...

> read on

Don't miss the SIFI Symposium Wavefront Engineering Extended Depth of Focus IOL Latest International Clinical & Scientific Updates on Sunday September 23rd from 1-2 PM ESCRS Room Straus 2 Moderator Prof. Gert Auffarth

> read on

Naples, 16 July 2018 09:30 to 16:30 Sala Posillipo, Eurostars Hotel Excelsior Via Partenope, 48, 80121 Naples ITALY Diabetic Macular Edema (EMD) is a degenerative ocular disease related to diabetes, severely disabling because of the progressive...

> read on

SIFI to strengthen R&D Pipeline with Pro-Ocular™ containing a neurosteroid with novel dosage delivery system that activates neural signaling to produce endogenous tear film without need for eye instillation SIFI, Italian leader in the development...

> read on

Don't miss the SIFI Symposium at the XIX G.I.Vre Italian Group of Vitreoretinal Surgery on treatment of diabetic macular edema presenting three-year data of the "real life" studies on the use of fluocinolone acetonide in the treatment of...

> read on